You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • OP0106 The impact of comorbidities on effect and discontinuation of tumour necrosis factor inhibitor therapy in psoriatic arthritis: a population-based cohort study

Article metrics

Article menu

Download PDFPDF

Oral Presentations
PsA: a fascinating disease
OP0106 The impact of comorbidities on effect and discontinuation of tumour necrosis factor inhibitor therapy in psoriatic arthritis: a population-based cohort study
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to August 2024

AbstractFullPdf
Jun 2017302
Jul 20172000
Aug 2017601
Sep 20171401
Oct 20171201
Nov 20171402
Dec 20171400
Jan 20181000
Feb 2018800
Mar 20181603
Apr 2018600
May 20185402
Jun 2018200
Jul 2018801
Aug 2018200
Sep 2018804
Oct 2018801
Nov 2018604
Dec 2018401
Jan 2019402
Feb 2019201
Mar 2019005
Apr 2019303
May 2019001
Jun 2019202
Jul 2019201
Aug 2019604
Sep 2019201
Oct 2019201
Nov 2019201
Dec 2019001
Jan 20201401
Feb 20201400
Mar 2020802
Apr 2020003
May 20201001
Jun 2020801
Jul 20201402
Aug 2020001
Sep 20201002
Oct 2020202
Nov 2020201
Dec 2020400
Jan 2021004
Feb 2021004
Mar 2021202
Apr 2021201
May 2021004
Jun 2021001
Jul 2021005
Aug 2021002
Sep 2021003
Oct 20216013
Nov 20210011
Dec 2021602
Jan 2022400
Feb 2022200
Mar 2022001
Apr 2022200
May 2022809
Jun 20221003
Jul 20221200
Aug 2022802
Sep 2022205
Oct 2022404
Nov 2022305
Dec 2022401
Jan 20231002
Feb 2023200
Mar 2023801
May 2023002
Jun 2023001
Jul 20233004
Aug 2023700
Sep 2023401
Oct 20231201
Nov 2023603
Dec 20231800
Jan 2024201
Feb 2024201
Mar 202414054
Apr 20241409
May 2024401
Jun 20241002
Jul 2024200
Aug 2024600
Total5520227